Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TULIP: Lipid-Lowering Effect of TDF/FTC in HIV-1 Patients With Dyslipidemia
NCT01458977Phase 4Completed
- Start
- Jan 2012
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in dyslipidemia. Started Jan 2012; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT01458977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01458977.